Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells-Reference-Cited by-同舟云学术

Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells

Published:2016-09-15 Issue:12 Volume:65 Page:1477-1489
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Kamata Toshiko,Suzuki Akane,Mise Naoko,Ihara Fumie,Takami Mariko,Makita Yuji,Horinaka Atsushi,Harada Kazuaki,Kunii Naoki,Yoshida Shigetoshi,Yoshino Ichiro,Nakayama Toshinori,Motohashi Shinichiro

Funder

Ministry of Education, Culture, Sports, Science and Technology

Ministry of Health, Labour and Welfare

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-016-1901-y.pdf

Reference37 articles.

1. Kawano T, Koezuka Y, Toura I et al (1997) CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278:1626–1629. doi: 10.1126/science.278.5343.1626

2. Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L (2012) Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 12:239–252. doi: 10.1038/nri3174

3. Taniguchi M, Seino K, Nakayama T (2003) The NKT cell system: bridging innate and acquired immunity. Nat Immunol 4:1164–1165. doi: 10.1038/ni1203-1164

4. Fujii S, Motohashi S, Shimizu K, Nakayama T, Yoshiga Y, Taniguchi M (2010) Adjuvant activity mediated by iNKT cells. Semin Immunol 22:97–102. doi: 10.1016/j.smim.2009.10.002

5. Konishi J, Yamazaki K, Yokouchi H, Shinagawa N, Iwabuchi K, Nishimura M (2004) The characteristics of human NKT cells in lung cancer-CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients. Hum Immunol 65:1377–1388. doi: 10.1016/j.humimm.2004.09.003

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cataloging circulating CD3+CD56+ NKT-like cells through a series of stimulating (NKG2D and DNAM-1) and inhibitory (PD-1, TIGIT, and Tim-3) immune checkpoint receptors in women diagnosed with precancerous cervical lesions or invasive cervical carcinoma;Immunology Letters;2024-10

2. Bona fidecytotoxic iNKT cells with superior antitumour responses identified in mice and humans;2024-07-22

3. Classification of regulatory T cells and their role in myocardial ischemia-reperfusion injury;Journal of Molecular and Cellular Cardiology;2024-01

4. The influence of anti-cancer therapies on lymphocyte subpopulations of lung cancer patients;Frontiers in Immunology;2023-08-28

5. The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function;Scientific Reports;2023-06-21